Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence. [PDF]
J Immunother CancerKött J +7 more
europepmc +1 more source
The Complex Role of MAPK/ERK Signaling Pathway in Different Types of Thrombocytopenia. [PDF]
Curr Issues Mol BiolXue P, Chen M.
europepmc +1 more source
Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Sci RepPriyadharshini A +4 more
europepmc +1 more source
Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper. [PDF]
AllergyCortellini G +10 more
europepmc +1 more source
Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPs. [PDF]
MoleculesShriwas P +8 more
europepmc +1 more source
When time flies by: very long-term complication of percutaneous occlusion of a large atrial septal defect-a case report. [PDF]
Eur Heart J Case RepGiaj Levra A +4 more
europepmc +1 more source
Improving the Appopriateness of Prescribing Medicine in the Elderly: A Comprehensive Approach in the Local Health Unit of Parma, Italy [PDF]
, 2010 Brianti, Ettore, MD +5 more
core +1 more source
Efficacy and safety of antiplatelet therapy for secondary prevention of small subcortical infarction: A systematic review and network meta-analysis. [PDF]
Eur Stroke JFeng X, Du J, Qu T, Xu S, Zhu W.
europepmc +1 more source
Interstitial pneumonitis following the implantation of a paclitaxel-eluting stent in a patient with peripheral arterial disease. [PDF]
J Vasc Surg Cases Innov TechHaga M, Iwata Y, Nitta J, Akasaka J.
europepmc +1 more source
Multivariate Adjustments for Average Equivalence Testing. [PDF]
Stat MedBoulaguiem Y +4 more
europepmc +1 more source